Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy
- Velia Ramírez-AmadorAffiliated withHealth Care Department, Universidad Autónoma Metropolitana-Xochimilco Email author
- , Gabriela Anaya-SaavedraAffiliated withHealth Care Department, Universidad Autónoma Metropolitana-Xochimilco
- , Erick Crespo-SolísAffiliated withInstituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”
- , Esther Irigoyen CamachoAffiliated withHealth Care Department, Universidad Autónoma Metropolitana-Xochimilco
- , Imelda González-RamírezAffiliated withHealth Care Department, Universidad Autónoma Metropolitana-Xochimilco
- , Sergio Ponce-de-LeónAffiliated withInstituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Knowledge of oral mucositis (OM) in patients with acute leukemia (AL) and chemotherapy (CT) has remained limited. Thus, a prospective, longitudinal study was undertaken to characterize clinical features, associated risk factors, and behavior of OM in a cohort of AL patients starting CT.
Prospective and longitudinal study. A cohort of patients, older than 15 years of age with AL, scheduled to receive CT, was followed from March 2006 to October 2007. At baseline and three times per week, for 21 days, patients had an oral examination performed using the Oral Mucositis Assessment Scale (OMAS); also, oral pain and difficulty to swallow were recorded using a visual analog scale. Weekly, salivary flow measurements (Schirmer’s test modified version) were done.
A cohort of 29 AL patients was followed for a median time of 21 (range, 14–53) days; 12 (41.4%) developed OM, with a mean OMAS score of 0.181 (SD ± 0.56) and a mean peak OMAS score of 1.8 (SD ± 0.56). The OM onset mean time was 9.8 (range, 2–20, SD ± 6.09) days, with a mean duration of 7 (range, 3–14, SD ± 4.15) days. OM was significantly correlated with salivary flow [rs = 0.420 (P = 0.0051)], oral pain [rs = 0.47 (P < 0.0001)], ability to swallow [rs = 0.36 (P = 0.0001)], and type of food intake [rs = 0.38 (P < 0.0001)].
OM is a frequent and early side effect of CT closely correlated with oral pain, difficulty to swallow, and impairment in food intake.
KeywordsOral mucositis Chemotherapy Acute leukemia Salivary flow
- Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy
Supportive Care in Cancer
Volume 18, Issue 5 , pp 639-646
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Oral mucositis
- Acute leukemia
- Salivary flow
- Industry Sectors
- Author Affiliations
- 1. Health Care Department, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100. Villa Quietud, 04960, Mexico City, Mexico
- 2. Instituto Nacional de Ciencias Médicas y Nutrición “Salvador Zubirán”, Mexico City, Mexico